Upon further analysis, a significant inverse association between GLP-1 RA use and mortality risk was observed, with those on GLP-1 RAs having a 62% lower odds of 5-year mortality compared with those not on GLP-1 RAs (odds ratio [OR], 0.38
Latest Clinical Trial Highlights (2026) Recent research continues evaluating: The precise IGF-1 multiplication factor when GHRH and GHRPs are combined
Choose Quality Supplements At Cymbiotika, we prioritize quality and transparency in our formulations
SIRT1 activation improves insulin sensitivity, enhances fat oxidation, and promotes mitochondrial biogenesis
Mol Hum Reprod (2010) 16:306
For each micronutrient, the following keywords were used: ((nutrient) OR (nutrient deficiency)) AND ((cancer prevention) OR (cancer protection)) ((nutrient) OR (nutrient deficiency)) AND ((protective effect) AND ((cancer) OR (oncology))) ((nutrient) OR (nutrient deficiency)) AND ((cancer risk) OR (cancer incidence) OR (cancer development)) ((nutrient) OR (nutrient deficiency)) AND (supplementation) AND ((cancer) OR (oncology)) ((nutrient) OR (nutrient deficiency)) AND (((toxicity) OR (toxicities) OR (adverse events) OR (adverse effects)) AND ((cancer) OR (oncology))) Only scientific articles (international guidelines, clinical trials, meta-analyses, systematic and narrative reviews) published until January 2025 and written in English were included